↓ Skip to main content

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

Overview of attention for article published in Frontiers in oncology, August 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
Published in
Frontiers in oncology, August 2021
DOI 10.3389/fonc.2021.704336
Pubmed ID
Authors

Wei Xiong, Yunfeng Zhao, He Du, Xuejun Guo

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 16%
Student > Master 6 12%
Other 4 8%
Student > Ph. D. Student 4 8%
Researcher 3 6%
Other 5 10%
Unknown 19 39%
Readers by discipline Count As %
Medicine and Dentistry 14 29%
Biochemistry, Genetics and Molecular Biology 5 10%
Agricultural and Biological Sciences 3 6%
Nursing and Health Professions 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 1 2%
Unknown 22 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2022.
All research outputs
#17,863,266
of 26,163,973 outputs
Outputs from Frontiers in oncology
#8,255
of 22,913 outputs
Outputs of similar age
#269,823
of 440,400 outputs
Outputs of similar age from Frontiers in oncology
#486
of 1,365 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,400 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,365 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.